Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer

Clinical trial NCT00019656 · COMPLETED

Trial details

NCT number: NCT00019656
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia Lymphoma Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Unspecified Adult Solid Tumor, Protocol Specific

Start date: 1999-08-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.